Blood antioxidant status and urinary levels of catecholamine metabolites in β-thalassemia

Free Radical Research

Volumn 30, Issue 6, 1999, Pages 453-462

  De Luca, Chiara ^a   Filosa, Aldo ^b   Grandinetti, Mauro ^a   Maggio, Francesco ^a   Lamba, Marta ^b   Passi, Siro ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

Author keywords

thalassemia; Antioxidant therapy; Catecholamines; Iron overload; Lipophilic antioxidants; Oxidative stress; Ubiquinone

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; AZELAIC ACID; BETA CAROTENE; CATECHOLAMINE; CHELATING AGENT; FATTY ACID; FERRITIN; LYCOPENE; PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE; RETINOL; SEROTONIN; THIOL; UBIQUINONE;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD LEVEL; BLOOD SAMPLING; BLOOD TRANSFUSION; CATECHOLAMINE URINE LEVEL; CHELATION THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; FERRITIN BLOOD LEVEL; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IRON OVERLOAD; LIPID PEROXIDATION; MALE; MASS SPECTROMETRY; METABOLITE; OXIDATIVE STRESS; SCHOOL CHILD; SPECTROPHOTOMETRY; URINALYSIS;

ADOLESCENT; ADULT; ANTIOXIDANTS; BETA-THALASSEMIA; BILIRUBIN; CAROTENOIDS; CATECHOLAMINES; CHILD; FATTY ACIDS; FEMALE; FERRITINS; HUMANS; IRON; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; SEROTONIN; SULFHYDRYL COMPOUNDS; UBIQUINONE; URIC ACID; VITAMINS;

HEPATITIS C VIRUS;

EID: 0032810030     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715769900300491     Document Type: Article

References (63)

1. D.J. Weatherall and J.B. Clegg (1982) Thalassemia revisited. Cell, 29, 7-9.
2. L. Zannos-Mariolea, F. Tzortzatou, K. Dendaki-Svolaki, C. Katerellos, M. Kavallari and N. Matsaniotis (1974) Serum vitamin E levels with β-thalassemia major: preliminary report. British Journal of Haematology, 26, 193-199.
3. E.A. Rachmilewitz, B.H. Lubin and S.B. Shohet (1976) Lipid membrane peroxidation in β-thalassemia major. Blood, 47, 495-505.
4. E. Shinar and E.A. Rachmilewitz (1990) Oxidative denaturation of red blood cells in thalassemia. Seminars in Haematology, 27, 70-82.
5. E.A. Proteasa and I. Ionescu (1995) Fatty acid peroxidation in relation to trace elements in serum of patients with homozygous sickle-cell anemia and β-thalassemia: a gas-chromatographic study. Nutrition, 11, 546-550.
6. M.A. Livrea, L. Tesoriere, A.M. Pintaudi, A. Calabrese, A. Maggio, H.L. Freisleben, R. D'Arpa and A. Bongiorno (1996) Oxidative stress and antioxidant status in β-thalassemia major: iron overload and depletion of lipid soluble antioxidants. Blood, 88, 3608-3614.
7. B. Modell and V. Berdoukas (1984) The Clinical Approach to Thalassemia. Grune and Stratton, London, Sydney, New York.
8. P.J. Giardina, R.W. Grady, K.H. Ehlers, M.I. New and W.M. Hilgartner (1993) Management of thalassemia major: fifteen years experience with subcutaneous desferrioxamine and hypertransfusion therapy. Clinical Research, 41, 313A.
9. S. Piomelli (1995) The management of patient with Cooley's anemia: Transfusion and splenectomy. Seminars in Haematology, 32, 262-268.
10. V. Gabutti and A. Piga (1996) Results of long term iron-chelating therapy. Acta Haematologica, 95, 26-36.
11. O. Shalev and R.P. Hebbel (1996) Extremely high avidity association of Fe(III) with the sickle red cell membrane. Blood, 88, 349-352.
12. T. Repka, O. Shalev, R. Reddy, J. Yuan, A. Abrahamov, E.A. Rachmilewitz, P.S. Low and R.P. Hebbel (1993) Non random association of free iron with membranes of sickle and thalassemic erythrocytes. Blood, 82, 3204-3210.
13. I. Kahane, A. Shifter and E.A. Rachmilewitz (1978) Cross-linking of red blood cells membrane proteins induced by oxidative stress in β-thalassemia. FEBS Letters, 85, 267-270.
14. S.L. Schrier, E. Rachmilewitz and N. Mohandas (1989) Cellular and membrane properties of α- and β-thalassemic erythrocytes are different: implications for differences in clinical manifestations. Blood, 74, 2194-2202.
15. J.J. Scott, P. van den Berg, T. Repka, P. Rouyer-Fessard, R.P. Hebbel, Y. Beuzard and B.H. Lubin (1993) Effect of excess α-hemoglobin chains on cellular and membrane oxidation in model β-thalassemia erythrocytes. Journal of Clinical Investigations, 91, 1706-1712.
16. M. Brunori, G. Falcioni, E. Fioretti, B. Giardina and G. Rotilio (1975) Formation of superoxide in the autoxidation of isolated α and β chains of human hemoglobin and its involvement in hemichrome precipitation. European Journal of Biochemistry, 53, 99-104.
17. L.M. Snyder, N.L. Fortier, L. Leb, J. McKenny, J. Trainor, H. Sheerin and N. Mohandas (1988) The role of membrane sulphydryl groups in hydrogen peroxide-mediated membrane damage in human erythrocytes. Biochimica et Biophysica Acta, 937, 229-240.
18. F. Grelloni, R. Gabbianelli, A.M. Santroni and G. Falcioni (1993) Inactivation of glutathione peroxidase following entrapment of purified α or β hemoglobin chains in human erythrocytes. Clinica Chimica Acta, 217, 187-192.
19. C. Hershko and E.A. Rachmilewitz (1975) Non transferrin plasma iron in patients with transfusional iron overload. In Proteins of Iron Storage and Transport in Biochemistry and Medicine (Ed. R.R. Crichton), Amersham, The Netherlands, North Holland, pp. 427-435.
20. C. Hershko, G. Graham, G.W. Bates and E.A. Rachmilewitz (1978) Non-specific serum iron in thalassemia: an abnormal serum specific iron fraction of potential toxicity. British Journal Hematology, 40, 225-263.
21. W.C. Wang, N. Ahmed and M. Hanna (1986) Non transferrin bound iron in long term transfusion in children with congenital anemias. Journal of Pediatrics, 108, 552-557.
22. B. Halliwell and J.M.C. Gutteridge (1990) Role of free radicals and catalytic metal ions in human disease: an overview. Methods in Enzymology, 186(Part B), 29-38.
23. P. Biemond, A.J.G. Swaak, H.G. Van Eijk and J.F. Koster (1988) Superoxide dependent iron release from ferritin in inflammatory diseases. Free Radicals in Biology and Medicine, 4, 185-198.
24. R.F. Boyer and C.J. McCleary (1987) Superoxide iron as a primary reductant in ascorbate mediated ferritin iron release. Free Radicals in Biology and Medicine, 3, 389-395.
25. J.B. Galey (1997) Potential use of iron chelators in oxidative damage. In Advances in Pharmacology, Vol. 38, (Ed. H. Sies), Academic Press, London and New York, pp. 167-203.
26. M.G. Zurlo, P. De Stefano, C. Borgna-Pignatti, A. Di Palma, A. Piga, C. Malevendi, F. Di Gregorio, M.G. Burattinia and S. Terzoli (1989) Survival and causes of death in thalassemia major. The Lancet, July 1, 27-30.
27. E.A. Rachmilewitz, A. Shifter and I. Kahane (1979) Vitamin E deficiency in β-thalassemia major: changes in hematological and biochemical parameters after a therapeutic trial with α-tocopherol. American Journal of Clinical Nutrition, 32, 1850-1858.
28. E.A. Rachmilewitz, A. Kornberg and M. Acker (1982) Vitamin E deficiency due to increased consumption in beta-thalassemia and in Gaucher's disease. Annals of the New York Academy of Sciences, 393, 336-347.
29. L.N. Grinberg, O. Shalev, A. Goldfarb and E.A. Rachmilewitz (1992) Primaquine-induced superoxide production by β-thalassemic red blood cells. Biochimica et Biophysica Acta, 1139, 248-250.
30. L. Palmieri, F. Ronca, S. Malengo and A. Bertelli (1994) Protection of β-thalassemic erythrocytes from oxidative stress by propionyl carnitine. International Journal of Tissue Reactions, XVI(3), 121-129.
31. O. David, L. Sacchetti, M.G. Vota, L. Comino, L. Perugini and G.P. Pescarmona (1990) Pyrimidine 5'-nucleotidase and oxidative damage in red blood cells transfused to β-thalassemic children. Haematologica, 75, 313-318.
32. S. Passi, M. Grandinetti, F. Maggio, A. Stancato and C. De Luca (1998) Epidermal oxidative stress in vitiligo. Pigment Cell Research, 11, 81-85.
33. P.A. Motchnik, B. Frei and B.N. Ames (1994) Measurement of antioxidants in human plasma. Methods in Enzymology, 234, 269-279.
34. S. Passi, A. Morrone, M. Picardo, C. De Luca and F. Ippolito (1991) Blood levels of vitamin E, polyunsaturated fatty acids of phospholipids, lipoperoxides and gluthatione peroxidase in patients affected with seborrheic dermatitis. Journal of Dermatological Sciences, 2, 171-178.
35. M.-L. Hu (1994) Measurement of protein thiol groups and glutathione in plasma. Methods in Enzymology, 233, 380-385.
36. S. Passi, M. Picardo, C. De Luca, M. Nazzaro-Porro, L. Rossi and G. Rotilio (1993) Saturated dicarboxylic acids as products of unsaturated fatty acid oxidation. Biochimica et Biophysica Acta, 1168, 190-198.
37. A. Morrone, M. Picardo, C. De Luca, O. Terminali, S. Passi and F. Ippolito (1992) Catecholamines and vitiligo. Pigment Cell Research, 5, 58-62.
38. S. Chirico, C. Smith, C. Marchant, M.J. Mitchinson and B. Halliwell (1993) Lipid peroxidation in hyperlipidemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. Free Radical Research Communications, 19, 51-57.
39. W.A. Pryor and L. Castle (1984) Chemical methods for detection of lipid hydroperoxides. Methods in Enzymology, 105, 293-299.
40. P. Faure and J.L. Lafond (1995) Measurement of plasma sulfhydryl and carbonyl groups as a possible indication of protein oxidation. In Analysis of Free Radicals in Biological Systems (Eds. A. Favier et al.), Bikhauser Verlag, Basel, Switzerland, pp. 237-248.
41. D. Zhang, S. Okada, T. Kawabata and T. Yasuda (1995) An improved simple colorimetric method for quantitation of non-transferrin-bound iron in serum. Biochemistry and Molecular Biology International, 35, 365-641.
42. E. Cadenas, P. Hochstein and L. Ernster (1992) Pro- and antioxidant functions of quinones and quinone reductases in mammalian cells. Advances in Enzymology, 65, 97-146.
43. L. Ernster and G. Dallner (1995) Biochemical, physiological and medical aspects of ubiquinone function. Biochimica et Biophysica Acta, 1271, 195-204.
44. B. Frei, M.C. Kim and B.N. Ames (1990) Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proceedings of the National Academy of Sciences USA, 87, 4878-4883.
45. D. Mohr, V.W. Bowry and R. Stocker (1992) Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoproteins to the initiation of lipid peroxidation. Biochimica et Biophysica Acta, 1126, 247-254.
46. L. Ernster, P. Forsmark and K. Nordenbrand (1992) The mode of action of lipid-soluble antioxidants in biological membranes: relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles. BioFactors, 3, 241-248.
47. S. Yamashita and Y. Yamamoto (1997) Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Analytical Biochemistry, 250, 66-73.
48. R. Stocker, A.N. Glazer and B. Ames (1987) Antioxidant activity of albumin bound bilirubin. Proceedings of the National Academy of Sciences USA, 84, 5918-5922.
49. B. Halliwell and J.M.C. Gutteridge (1989) Lipid peroxidation: a radical chain reaction. In Free Radicals in Biology and Medicine, 2nd edn. (Eds. B. Halliwell and J.M.C. Gutteridge), Clarendon Press, Oxford, UK, pp. 253-260.
50. J.M.C. Gutteridge and B. Halliwell (1994) Antioxidants in Nutrition, Health, and Disease. Oxford University Press, Oxford-New York-Tokyo.
51. M. Podda, M.G. Traber, C. Weber, L.-J. Yan and L. Packer (1998) UV-irradiation depletes antioxidants and causes oxidative damage in a model of human skin. Free Radicals in Biology and Medicine, 24, 55-65.
52. J.B. Porter, R.D. Abeysinghe, L. Marshall, R.C. Hider and S. Singh (1996) Kinetics of removal and reappearance of non transferrin bound plasma iron with desferrioxamine therapy. Blood, 88, 705-713.
53. P.J. Giardina and R.W. Grady (1995) Chelation therapy in β-thalassemia: the benefits and limitations of desferrioxamine. Seminars in Hematology, 32, 304-312.
54. M. Hatori, J. Sparkman, C.C. Teixeira, M. Grynpas, J. Nervina, N. Olivieri and I.M. Shapiro (1995) Effects of deferoximine on chondrocyte alkaline phosphatase activity: Proxidant role of deferoximine in thalassemia. Calcified Tissue International, 57, 229-236.
55. C. Choremis, V. Kiriakides and E. Papadakis (1961) Journal of Clinical Pathology, 14, 361-365.
56. M. Maioli, G.B. Cuccuru, P. Pranzetti, A. Pacifico and G.M. Cherchi (1984) Plasma lipids and lipoprotein pattern in beta thalassemia major. Acta Haematologica, 71, 106-110.
57. O. Giardini, F. Murgia, F. Martino, O. Mannarino, G. Corrado and G. Maggioni (1978) Serum lipid pattern in β-thalassemia. Acta Haematologica, 60, 100-107.
58. 10 Association, Boston, USA, May 21-24, 1998, pp. 129-131.
59. B.B. Hoffman and R.J. Lefkowitz (1996) Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edn. (Eds. J.G. Hardman, L.E. Limbird and A. Goodman Gilman), McGraw-Hill, New York, pp. 199-248.
60. E. Sanders-Bush and S.E. Mayer (1996) 5-Hydroxytryptamine (serotonin) receptor agonists and antagonists. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edn. (Eds. J.G. Hardman, L.E. Limbird and A. Goodman Gilman), McGraw-Hill, New York, pp. 249-263.
61. I. Kahane and E.A. Rachmilewitz (1976) Alterations in the red blood cell membrane and the effect of vitamin E on osmotic fragility in beta-thalassemia major. Israel Journal of Medical Sciences, 12, 11-15.
62. O. Giardini, A. Cantani, A. Donfrancesco, F. Martino, O. Mannarino, P. D'Eufemia, C. Miano, U. Ruberto and R. Lubrano (1985) Biochemical and clinical effects of vitamin E administration in homozygous beta-thalassemia. Acta Vitaminologica et Enzymologica, 7, 55-60.
63. L. Bianco, R. Boccaccini, P. Capalbo, G. Morici, M. Maestro and M. Mandrino (1986) The role of vitamin E in the therapy of thalassemia. Pediatr Med Chir, 8, 23-26.